MARATTO

article · New England Journal of Medicine

Low-Dose Yellow Fever Vaccine in Adults in Africa

202511 citationsOpen accessMoi University

Abstract

A yellow fever vaccination dose as low as 500 IU was noninferior to the standard dose of 13,803 IU for producing seroconversion within 28 days. (Funded by the European and Developing Countries Clinical Trials Partnership and the Wellcome Trust; NIFTY ClinicalTrials.gov number, NCT04059471.).

Research topics

  • Mosquito-borne diseases and control
  • Viral Infections and Outbreaks Research
  • Viral Infections and Vectors

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1056/nejmoa2407293

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.